{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:56:20Z","timestamp":1793105780046,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s12094-019-02240-6","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T16:02:30Z","timestamp":1573833750000},"page":"1138-1145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Ganoderic acid A\/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0086-4760","authenticated-orcid":false,"given":"A.","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Alshareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"F.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Martinez Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"W. A.","family":"Vandergrift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Lindhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. K.","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Infinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cachia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"issue":"11","key":"2240_CR1","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1586\/14737175.6.11.1671","volume":"6","author":"C Hartmann","year":"2006","unstructured":"Hartmann C, Bostrom J, Simon M. Diagnostic and molecular pathology of meningiomas. Expert Rev Neurother. 2006;6(11):1671\u201383.","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"2240_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11060-010-0348-9","volume":"99","author":"S Hanft","year":"2010","unstructured":"Hanft S, Canoll P, Bruce JN. A review of malignant meningiomas: diagnosis, characteristics, and treatment. J Neurooncol. 2010;99(3):433\u201343.","journal-title":"J Neurooncol"},{"issue":"3","key":"2240_CR3","first-page":"197","volume":"74","author":"A Herbst","year":"2013","unstructured":"Herbst A, Mueller-Vogt U, Brawanski A, Proescholdt M, Riemenschneider MJ, Schebesch KM. WHO grade III anaplastic meningioma metastasizing to the parotid gland and the lungs: case report and review of the literature. J Neurol Surg A Cent Eur Neurosurg. 2013;74(3):197\u2013202.","journal-title":"J Neurol Surg A Cent Eur Neurosurg"},{"issue":"5","key":"2240_CR4","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/foc.2005.19.5.10","volume":"19","author":"BT Ragel","year":"2005","unstructured":"Ragel BT, Jensen RL. Molecular genetics of meningiomas. Neurosurg Focus. 2005;19(5):E9.","journal-title":"Neurosurg Focus"},{"issue":"1","key":"2240_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11060-010-0291-9","volume":"102","author":"D Skiriute","year":"2011","unstructured":"Skiriute D, Tamasauskas S, Asmoniene V, Saferis V, Skauminas K, Deltuva V, Tamasauskas A. Tumor grade-related NDRG2 gene expression in primary and recurrent intracranial meningiomas. J Neurooncol. 2011;102(1):89\u201394.","journal-title":"J Neurooncol."},{"issue":"16","key":"2240_CR6","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-05-0043","volume":"65","author":"EA Lusis","year":"2005","unstructured":"Lusis EA, Watson MA, Chicoine MR, Lyman M, Roerig P, Reifenberger G, Gutmann DH, Perry A. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res. 2005;65(16):7121\u20136.","journal-title":"Cancer Res"},{"issue":"1","key":"2240_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbrc.2013.10.010","volume":"441","author":"A Yamamura","year":"2013","unstructured":"Yamamura A, Miura K, Karasawa H, Morishita K, Abe K, Mizuguchi Y, Saiki Y, Fukushige S, Kaneko N, Sase T, Nagase H, Sunamura M, Motoi F, Egawa S, Shibata C, Unno M, Sasaki I, Horii A. Suppressed expression of NDRG2 correlates with poorprognosis in pancreatic cancer. Biochem Biophys Res Commun. 2013;441(1):102\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2240_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.canlet.2011.06.015","volume":"310","author":"L Gao","year":"2011","unstructured":"Gao L, Wu GJ, Liu XW, Zhang R, Yu L, Zhang G, Liu F, Yu CG, Yuan JL, Wang H, Yao LB. Suppression of invasion and metastasis of prostate cancer cells by overexpression of NDRG2 gene. Cancer Lett. 2011;310(1):94\u2013100.","journal-title":"Cancer Lett"},{"issue":"5","key":"2240_CR9","first-page":"577","volume":"21","author":"J Jiang","year":"2008","unstructured":"Jiang J, Grieb B, Thyagarajan A, Sliva D. Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling. Int J Mol Med. 2008;21(5):577\u201384.","journal-title":"Int J Mol Med"},{"key":"2240_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/1471-2407-13-305","volume":"13","author":"W Cao","year":"2013","unstructured":"Cao W, Yu G, Lu Q, Zhang J. Low expression of N-myc downstream-regulated gene 2 in oesophageal squamous cell carcinoma correlates with a poor prognosis. BMC Cancer. 2013;13:305.","journal-title":"BMC Cancer"},{"issue":"5","key":"2240_CR11","first-page":"6515","volume":"16","author":"Y Yang","year":"2018","unstructured":"Yang Y, Zhou H, Liu W, Wu J, Yue X, Wang J, Quan L, Liu H, Guo L, Wang Z, Lian X, Zhang Q. Ganoderic acid A exerts antitumor activity against MDA-MB-231 human breast cancer cells by inhibiting the Janus kinase 2\/signal transducer and activator of transcription 3 signaling pathway. Oncol Lett. 2018;16(5):6515\u201321.","journal-title":"Oncol Lett"},{"issue":"4","key":"2240_CR12","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.3892\/mmr.2017.7048","volume":"16","author":"X Wang","year":"2017","unstructured":"Wang X, Sun D, Tai J, Wang L. Ganoderic acid A inhibits proliferation and invasion, and promotes apoptosis in human hepatocellular carcinoma cells. Mol Med Rep. 2017;16(4):3894\u2013900.","journal-title":"Mol Med Rep"},{"issue":"12","key":"2240_CR13","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s11033-016-4074-z","volume":"43","author":"BS Gill","year":"2016","unstructured":"Gill BS, Kumar S, Navgeet. Evaluating anti-oxidant potential of ganoderic acid A in STAT 3 pathway in prostate cancer. Mol Biol Rep. 2016;43(12):1411\u201322.","journal-title":"Mol Biol Rep"},{"key":"2240_CR14","first-page":"780892","volume":"2012","author":"S Teekachunhatean","year":"2012","unstructured":"Teekachunhatean S, Sadja S, Ampasavate C, Chiranthanut N, Rojanasthien N, Sangdee C. Pharmacokinetics of ganoderic acids a and f after oral administration of ling zhi preparation in healthy male volunteers. J Evid Based Complementary Altern Med. 2012;2012:780892.","journal-title":"J Evid Based Complementary Altern Med"},{"issue":"2","key":"2240_CR15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.fitote.2011.12.004","volume":"83","author":"GS Wu","year":"2012","unstructured":"Wu GS, Lu JJ, Guo JJ, Li YB, Tan W, Dang YY, Zhong ZF, Xu ZT, Chen XP, Wang YT. Ganoderic acid DM, a natural triterpenoid, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Fitoterapia. 2012;83(2):408\u201314.","journal-title":"Fitoterapia"},{"issue":"6","key":"2240_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.4172\/2155-9899.1000535","volume":"8","author":"JM Bryant","year":"2017","unstructured":"Bryant JM, Bouchard M, Haque A. Anticancer activity of ganoderic acid DM: Current status and future perspective. J Clin Cell Immunol. 2017;8(6):535.","journal-title":"J Clin Cell Immunol."},{"issue":"9","key":"2240_CR17","doi-asserted-by":"publisher","first-page":"7027","DOI":"10.1007\/s13277-015-3388-0","volume":"36","author":"A Das","year":"2015","unstructured":"Das A, Miller R, Lee P, Holden CA, Lindhorst SM, Jaboin J, Vandergrift WA 3rd, Banik NL, Giglio P, Varma AK, Raizer JJ, Patel SJ. A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt\/\u03b2-catenin signaling pathway. Tumour Biol. 2015;36(9):7027\u201334.","journal-title":"Tumour Biol"},{"issue":"3","key":"2240_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.surneu.2007.06.031","volume":"70","author":"BT Ragel","year":"2008","unstructured":"Ragel BT, Couldwell WT, Gillespie DL, Wendland MM, Whang K, Jensen RL. A comparison of the cell lines used in meningioma research. Surg Neurol. 2008;70(3):295\u2013307 (discussion).","journal-title":"Surg Neurol."},{"issue":"1","key":"2240_CR19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/cncr.24699","volume":"116","author":"A Das","year":"2010","unstructured":"Das A, Banik NL, Ray SK. Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes. Cancer. 2010;116(1):164\u201376.","journal-title":"Cancer"},{"issue":"10","key":"2240_CR20","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1111\/j.1582-4934.2008.00539.x","volume":"13","author":"J George","year":"2009","unstructured":"George J, Banik NL, Ray SK. Combination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells and inhibits invasion, angiogenesis and tumour growth. J Cell Mol Med. 2009;13(10):4205\u201318.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"2240_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11060-010-0331-5","volume":"99","author":"M Kalamarides","year":"2010","unstructured":"Kalamarides M, Peyre M, Giovannini M. Meningioma mouse models. J Neurooncol. 2010;99(3):325\u201331.","journal-title":"J Neurooncol"},{"issue":"2","key":"2240_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1750-3639.2007.00109.x","volume":"18","author":"GS Baia","year":"2008","unstructured":"Baia GS, Dinca EB, Ozawa T, Kimura ET, McDermott MW, James CD, VandenBerg SR, Lal A. An orthotopic skull base model of malignant meningioma. Brain Pathol. 2008;18(2):172\u20139.","journal-title":"Brain Pathol"},{"issue":"1","key":"2240_CR23","first-page":"162","volume":"93","author":"FK Miura","year":"2000","unstructured":"Miura FK, Cekic O, Moriuchi S, Aguiar PH. Meningioma model. J Neurosurg. 2000;93(1):162\u20133.","journal-title":"J Neurosurg"},{"issue":"3","key":"2240_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00001622-200305000-00005","volume":"15","author":"SS Prabhu","year":"2003","unstructured":"Prabhu SS, Demonte F. Treatment of skull base tumors. Curr Opin Oncol. 2003;15(3):209\u201312.","journal-title":"Curr Opin Oncol"},{"issue":"Suppl 2","key":"2240_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0168-8278(97)80494-1","volume":"26","author":"F Ballet","year":"1997","unstructured":"Ballet F. Hepatotoxicity in drug development: detection, significance and solutions. J Hepatol. 1997;26(Suppl 2):26\u201336.","journal-title":"J Hepatol"},{"issue":"2","key":"2240_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF02703705","volume":"30","author":"S Atici","year":"2005","unstructured":"Atici S, Cinel I, Cinel L, Doruk N, Eskandari G, Oral U. Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model. J Biosci. 2005;30(2):245\u201352.","journal-title":"J Biosci"},{"issue":"6","key":"2240_CR27","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00280-018-3684-7","volume":"82","author":"A Das","year":"2018","unstructured":"Das A, Henderson F Jr, Lowe S, Wallace GC 4th, Vandergrift WA 3rd, Lindhorst SM, Varma AK, Infinger LK, Giglio P, Banik NL, Patel SJ, Cachia D. Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma. Cancer Chemother Pharmacol. 2018;82(6):945\u201352.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"2240_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11060-013-1165-8","volume":"114","author":"GCT Wallace","year":"2013","unstructured":"Wallace GCT, Haar CP, Vandergrift WA 3rd, Giglio P, Dixon-Mah YN, Varma AK, Ray SK, Patel SJ, Banik NL, Das A. Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition. J Neurooncol. 2013;114(1):43\u201350.","journal-title":"J Neurooncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-019-02240-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-019-02240-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-019-02240-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T01:01:53Z","timestamp":1722042113000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-019-02240-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["2240"],"URL":"https:\/\/doi.org\/10.1007\/s12094-019-02240-6","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]},"assertion":[{"value":"4 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Subjects gave their written, informed consent to participate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}